Screener
Dianthus Therapeutics DNTH Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Dianthus Therapeutics’s reported figures.
The source filing: Dianthus Therapeutics’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001690585-26-000022
FAQ
- What is Dianthus Therapeutics's free cash flow?
- Dianthus Therapeutics (DNTH) reported free cash flow of -$28.87M in Q1 2026.
- How has Dianthus Therapeutics's free cash flow changed year-over-year?
- Dianthus Therapeutics's free cash flow decreased by 4.4% year-over-year, from -$27.65M to -$28.87M.
- What is the long-term trend for Dianthus Therapeutics's free cash flow?
- Over 2 years (2021 to 2024), Dianthus Therapeutics's free cash flow has grown at a 13.5% compound annual growth rate (CAGR), from -$60.8M to -$78.29M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Dianthus Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude